Bayer Schering Pharma AG v. Lupin Ltd
2:10-cv-01166
Overview
Case Number
2:10-cv-01166
Filing Date
2010-07-15
Status
Litigation filed
Court
District Court, D. Nevada (nvd)
Nature of Suit
830 Patent
Cause of Action
35:271 Patent Infringement
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Nevada (nvd)
Docket Entries
COMPLAINT against Lupin Ltd, Lupin Pharmaceuticals Inc. (Filing fee $ 350 receipt number 0978-1676121), filed by Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc.. Certificate of Interested Parties due by 7/25/2010. Proof of service due by 11/12/2010. (Attachments: # 1 Exhibit Exh 1 to Complaint, # 2 Exhibit Exh 2 to Complaint, # 3 Exhibit Exh 3 to Complaint, # 4 Civil Cover Sheet Civil Cover Sheet, # 5 Summons Lupin Ltd., # 6 Summons Lupin Pharmaceuticals, Inc.)(Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
1
COMPLAINT against Lupin Ltd, Lupin Pharmaceuticals Inc. (Filing fee $ 350 receipt number 0978-1676121), filed by Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc.. Certificate of Interested Parties due by 7/25/2010. Proof of service due by 11/12/2010. (Attachments: # 1 Exhibit Exh 1 to Complaint, # 2 Exhibit Exh 2 to Complaint, # 3 Exhibit Exh 3 to Complaint, # 4 Civil Cover Sheet Civil Cover Sheet, # 5 Summons Lupin Ltd., # 6 Summons Lupin Pharmaceuticals, Inc.)(Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
2
COMPLAINT against Lupin Ltd, Lupin Pharmaceuticals Inc. (Filing fee $ 350 receipt number 0978-1676121), filed by Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc.. Certificate of Interested Parties due by 7/25/2010. Proof of service due by 11/12/2010. (Attachments: # 1 Exhibit Exh 1 to Complaint, # 2 Exhibit Exh 2 to Complaint, # 3 Exhibit Exh 3 to Complaint, # 4 Civil Cover Sheet Civil Cover Sheet, # 5 Summons Lupin Ltd., # 6 Summons Lupin Pharmaceuticals, Inc.)(Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
2
COMPLAINT against Lupin Ltd, Lupin Pharmaceuticals Inc. (Filing fee $ 350 receipt number 0978-1676121), filed by Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc.. Certificate of Interested Parties due by 7/25/2010. Proof of service due by 11/12/2010. (Attachments: # 1 Exhibit Exh 1 to Complaint, # 2 Exhibit Exh 2 to Complaint, # 3 Exhibit Exh 3 to Complaint, # 4 Civil Cover Sheet Civil Cover Sheet, # 5 Summons Lupin Ltd., # 6 Summons Lupin Pharmaceuticals, Inc.)(Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
2
COMPLAINT against Lupin Ltd, Lupin Pharmaceuticals Inc. (Filing fee $ 350 receipt number 0978-1676121), filed by Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc.. Certificate of Interested Parties due by 7/25/2010. Proof of service due by 11/12/2010. (Attachments: # 1 Exhibit Exh 1 to Complaint, # 2 Exhibit Exh 2 to Complaint, # 3 Exhibit Exh 3 to Complaint, # 4 Civil Cover Sheet Civil Cover Sheet, # 5 Summons Lupin Ltd., # 6 Summons Lupin Pharmaceuticals, Inc.)(Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
2
COMPLAINT against Lupin Ltd, Lupin Pharmaceuticals Inc. (Filing fee $ 350 receipt number 0978-1676121), filed by Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc.. Certificate of Interested Parties due by 7/25/2010. Proof of service due by 11/12/2010. (Attachments: # 1 Exhibit Exh 1 to Complaint, # 2 Exhibit Exh 2 to Complaint, # 3 Exhibit Exh 3 to Complaint, # 4 Civil Cover Sheet Civil Cover Sheet, # 5 Summons Lupin Ltd., # 6 Summons Lupin Pharmaceuticals, Inc.)(Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
2
COMPLAINT against Lupin Ltd, Lupin Pharmaceuticals Inc. (Filing fee $ 350 receipt number 0978-1676121), filed by Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc.. Certificate of Interested Parties due by 7/25/2010. Proof of service due by 11/12/2010. (Attachments: # 1 Exhibit Exh 1 to Complaint, # 2 Exhibit Exh 2 to Complaint, # 3 Exhibit Exh 3 to Complaint, # 4 Civil Cover Sheet Civil Cover Sheet, # 5 Summons Lupin Ltd., # 6 Summons Lupin Pharmaceuticals, Inc.)(Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
2
CERTIFICATE of Interested Parties filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG that identifies all parties that have an interest in the outcome of this case. Corporate Parent Bayer AG, Other Affiliate Bayer Corporation, Other Affiliate Bayer Healthcare Pharmaceuticals Inc., Other Affiliate Bayer Schering Pharma AG, Other Affiliate Schering Berlin, Inc., Other Affiliate Bayer HealthCare LLC, Other Affiliate BlackRock, Inc., Other Affiliate Capital Research and Management Company, Other Affiliate BlackRock Financial Management, Inc., Other Affiliate BlackRock Holdco2, Inc., Other Affiliate BR Jersey International Holdings L.P., Other Affiliate BlackRock International Holdings, Inc., Other Affiliate BlackRock Group Limited for Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG added.. (Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
1
NOTICE PURSUANT TO LOCAL RULE IB 2-2: In accordance with 28 USC § 636(c) and FRCP 73, the parties in this action are provided with a link to the "AO 85 Notice of Availability, Consent, and Order of Reference - Exercise of Jurisdiction by a U.S. Magistrate Judge" form on the Court's website - www.nvd.uscourts.gov. Consent forms should NOT be electronically filed. Upon consent of all parties, counsel are advised to manually file the form with the Clerk's Office. (no image attached) (ECS) (Entered: 07/15/2010)
2010-07-15
1
Summons Issued as to Lupin Ltd, Lupin Pharmaceuticals Inc. re 1 Complaint. (Attachments: # 1 Summons)(ECS) (Entered: 07/15/2010)
2010-07-15
1
NOTICE TO COUNSEL PURSUANT TO LOCAL RULE IA 10-2. Counsel Peter B. Bensinger Jr, Paul J. Skiermont, Adam K. Mortara, Sundeep K. Addy, and Matthew R. Ford to comply with completion and electronic filing of the Designation of Local Counsel and Verified Petition. For your convenience, click on the following link to obtain the form from the Court's website - www.nvd.uscourts.gov/Forms.aspx. Counsel is also required to register for the Court's Case Management and Electronic Case Filing (CM/ECF) system and the electronic service of pleadings. Please visit the Court's website www.nvd.uscourts.gov to register Attorney(s). Verified Petition due by 8/29/2010.(no image attached) (ECS) (Entered: 07/15/2010)
2010-07-15
1
AO 120 - REPORT on the filing of an action regarding a patent. E-mailed to the US Patent and Trademark Office. (Attachments: # 1 Complaint) (ECS) (Entered: 07/15/2010)
2010-07-15
1
NOTICE OF RELATED CASES 2:08-cv-00995-KJF-GWF Consolidated with 2:07-cv-01472-KJD-GWF Basefile by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 07/15/2010)
2010-07-15
1
MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Roger L. Hunt, on 7/21/2010. IT IS ORDERED that this case is reassigned to the Honorable U.S. District Court Judge Gloria M. Navarro for all further proceedings. The Honorable U.S. District Court Judge Robert C. Jones is no longer assigned to this case. All further documents must bear the correct case number 2:10-cv-01166-GMN-RJJ. (no image attached) (Copies have been distributed pursuant to the NEF - AF) (Entered: 07/21/2010)
2010-07-21
1
Joint MOTION to Consolidate Cases WITH REQUEST FOR EXPEDITED HEARING ON ORDER SHORTENING TIME, TO CONSOLIDATE RELATED CASES by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Responses due by 10/11/2010. (Attachments: # 1 Exhibit A)(Williams, Nikkya) (Entered: 09/24/2010)
2010-09-24
1
ANSWER to 1 Complaint,, ( Certificate of Interested Parties due by 10/7/2010., Discovery Plan/Scheduling Order due by 11/11/2010.), COUNTERCLAIM against Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG filed by Lupin Pharmaceuticals Inc., Lupin Ltd.(Whitmire, III, James) (Entered: 09/27/2010)
2010-09-27
1
CERTIFICATE of Interested Parties filed by Lupin Ltd, Lupin Pharmaceuticals Inc.. There are no known interested parties other than those participating in the case. (Whitmire, III, James) (Entered: 09/27/2010)
2010-09-27
1
Bayer's ANSWER to 10 Answer to Complaint,, Counterclaim, to Lupin's Counterclaims filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG.(Fountain, Jonathan) (Entered: 10/21/2010)
2010-10-21
1
Submission of PROPOSED ORDER filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc. Joint Proposed Protective Order. (Whitmire, III, James) (Entered: 10/21/2010)
2010-10-21
1
NOTICE by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG Notice of Reply to Watson and Sandoz's Joint Opposition to Bayer and Lupin's Joint Motion to Consolidate, Filed in Related Case No. 2:07-cv-01472-KJD-GWF (Attachments: # 1 Exhibit A)(Fountain, Jonathan) (Entered: 10/21/2010)
2010-10-21
1
REPLY to Response to 9 Joint MOTION to Consolidate Cases WITH REQUEST FOR EXPEDITED HEARING ON ORDER SHORTENING TIME, TO CONSOLIDATE RELATED CASES ; filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. (Whitmire, III, James) (Entered: 10/22/2010)
2010-10-22
1
MOTION to Seal "Confidential" Reply in Support of the Joint Motion to Consolidate by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 10/22/2010. (Whitmire, III, James) (Entered: 10/22/2010)
2010-10-22
1
PROTECTIVE ORDER re 13 Proposed Joint Protective Order. Signed by Magistrate Judge Robert J. Johnston on 10/26/10. (Copies have been distributed pursuant to the NEF - EDS)
2010-10-26
1
ORDER Granting 16 Defendants Lupin Limited's and Lupin Pharmaceuticals, Inc's Motion to Seal Reply in Support of Joint Motion to Consolidate. Signed by Magistrate Judge Robert J. Johnston on 10/26/10. (Copies have been distributed pursuant to the NEF - EDS)
2010-10-26
1
NOTICE TO COUNSEL PURSUANT TO LOCAL RULE IA 10-2. Counsel Robert F. Green, Christopher T. Griffith, Salim A. Hasan, and Kate M. Lesciotto to comply with completion and electronic filing of the Designation of Local Counsel and Verified Petition. For your convenience, click on the following link to obtain the form from the Court's website - www.nvd.uscourts.gov/Forms.aspx. Counsel is also required to register for the Court's Case Management and Electronic Case Filing (CM/ECF) system and the electronic service of pleadings. Please visit the Court's website www.nvd.uscourts.gov to register Attorney(s). Verified Petition due by 11/11/2010.(no image attached) (MJZ) (Entered: 10/26/2010)
2010-10-26
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Salim A. Hasan, Esq. and DESIGNATION of Local Counsel James E. Whitmire, Esq. (Filing fee $ 175 receipt number 0978-1784420) filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 11/3/2010. (Whitmire, III, James) (Entered: 11/03/2010)
2010-11-03
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Robert F. Green, Esq. and DESIGNATION of Local Counsel James E. Whitmire, Esq. (Filing fee $ 175 receipt number 0978-1784499) filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 11/3/2010. (Whitmire, III, James) (Entered: 11/03/2010)
2010-11-03
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Kate M. Lesciotto, Esq. and DESIGNATION of Local Counsel James E. Whitmire, Esq. (Filing fee $ 175 receipt number 0978-1784534) filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 11/3/2010. (Whitmire, III, James) (Entered: 11/03/2010)
2010-11-03
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Christopher T. Griffith, Esq. and DESIGNATION of Local Counsel James E. Whitmire, Esq. (Filing fee $ 175 receipt number 0978-1784567) filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 11/3/2010. (Whitmire, III, James) (Entered: 11/03/2010)
2010-11-03
1
ORDER Granting 20 Verified Petition for Permission to Practice Pro Hac Vice for Attorney Salim A. Hasan and approving Attorney Jim Whitmire as Designation of Local Counsel for Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. Signed by Judge Gloria M. Navarro on 11/3/10. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - EDS) (Entered: 11/04/2010)
2010-11-03
1
ORDER Granting 21 Verified Petition for Permission to Practice Pro Hac Vice for Attorney Robert F. Green and approving Attorney Jim Whitmire as Designation of Local Counsel for Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. Signed by Judge Gloria M. Navarro on 11/3/10. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - EDS) (Entered: 11/04/2010)
2010-11-03
1
ORDER Granting 22 Verified Petition for Permission to Practice Pro Hac Vice for Attorney Kate M. Lesciotto and approving Attorney Jim Whitmire as Designation of Local Counsel for Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. Signed by Judge Gloria M. Navarro on 11/3/10. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - EDS) (Entered: 11/04/2010)
2010-11-03
1
ORDER Granting 23 Verified Petition for Permission to Practice Pro Hac Vice for Attorney Christopher T. Griffith and approving Attorney Jim Whitmire as Designation of Local Counsel for Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. Signed by Judge Gloria M. Navarro on 11/3/10. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - EDS) (Entered: 11/04/2010)
2010-11-03
1
PROPOSED Discovery Plan/Scheduling Order filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Fountain, Jonathan) 29 Corrected image filed on 11/12/2010. (MJZ) (Entered: 11/10/2010)
2010-11-10
1
NOTICE of Corrected Image/Document re 28 Proposed Discovery Plan/Scheduling Order, by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Service of corrected image is attached). (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Fountain, Jonathan) (Entered: 11/12/2010)
2010-11-12
1
ORDER that the Corrected Re-Filing of Stipulated Consolidated Joint Discovery Plan and Scheduling Order 29 is GRANTED. Further, the Court adopts the Stipulated Consolidated Joint Discovery Plan and Scheduling Order attached as Exhibit 1 to the Corrected Re-Filing 29 . The Re-Filing 28 is MOOT based on the Corrected Re-Filing 29 . Signed by Magistrate Judge Robert J. Johnston on 11/17/10. (Copies have been distributed pursuant to the NEF - ECS)
2010-11-17
1
NOTICE OF RELATED CASES 08-00995, 07-01472, 11-00054 by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 01/12/2011)
2011-01-12
1
MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Roger L. Hunt, on 1/19/2011. To properly distribute the case load for the magistrate judges in the District of Nevada, IT IS ORDERED that this case is reassigned to Judge George W. Foley, Jr., U.S. Magistrate Judge for all further proceedings consistent with his jurisdiction. All further documents must bear the correct case number 2:10-cv-01166-GMN-GWF. (no image attached) (Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/19/2011)
2011-01-19
1
MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Roger L. Hunt, on 1/20/2011. IT IS ORDERED that this case is reassigned back to Magistrate Judge Robert J. Johnston for all further proceedings consistent with his jurisdiction. Magistrate Judge George Foley, Jr. is no longer assigned to case. All further documents must bear the correct case number 2-10-cv-1166-GMN-RJJ.(no image attached)(Copies have been distributed pursuant to the NEF - LG) (Entered: 01/20/2011)
2011-01-20
1
MOTION to Expedite Motion, with Request for Order Shortening Time, to Schedule Claim Construction Proceedings ("Markman Proceeding") on Expedited Basis by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 1/28/2011. (Whitmire, III, James) (Entered: 01/28/2011)
2011-01-28
1
RESPONSE to 34 MOTION to Expedite Motion, with Request for Order Shortening Time, to Schedule Claim Construction Proceedings ("Markman Proceeding") on Expedited Basis MOTION to Expedite Motion, with Request for Order Shortening Time, to Schedule Claim Construction Proceedings ("Markman Proceeding") on Expedited Basis, filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Bayer's Opposition to Lupin's Motion to Schedule Claim Construction Proceedings on an Expedited Basis Replies due by 2/13/2011. (Attachments: # 1 Declaration Declaration of Sundeep K. Addy in Opposition to Lupin's Motion to Schedule Claim Construction Proceedings on an Expedited Basis, # 2 Exhibit Exhibit 1 to Declaration of Sundeep K. Addy, # 3 Exhibit Exhibit 2 to Declaration of Sundeep K. Addy, # 4 Exhibit Exhibit 3 to Declaration of Sundeep K. Addy)(Fountain, Jonathan) (Entered: 02/03/2011)
2011-02-03
1
PROPOSED Discovery Plan/Scheduling Order filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 02/04/2011)
2011-02-04
1
REPLY to Response to 34 MOTION to Expedite Motion, with Request for Order Shortening Time, to Schedule Claim Construction Proceedings ("Markman Proceeding") on Expedited Basis MOTION to Expedite Motion, with Request for Order Shortening Time, to Schedule Claim Construction Proceedings ("Markman Proceeding") on Expedited Basis ; filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc.. (Whitmire, III, James) (Entered: 02/07/2011)
2011-02-07
1
ORDER that Plaintiffs Bayer Schering Pharma AG and Bayer Healthcare Pharmaceuticals Inc. and Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.s Joint Motion to Consolidate 9 is DENIED. Signed by Judge Gloria M. Navarro on 3/1/11. (Copies have been distributed pursuant to the NEF - ECS)
2011-03-01
1
OBJECTION to 38 Order on Motion to Consolidate Cases, ; filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 03/08/2011)
2011-03-08
1
AMENDED ORDER that Plaintiffs Bayer Schering Pharma AG and Bayer Healthcare Pharmaceuticals Inc. and Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc's Joint Motion to Consolidate 9 is DENIED without prejudice to a future motion to consolidate if there is a change in circumstances supporting such a motion. Signed by Judge Gloria M. Navarro on 3/8/11. (Copies have been distributed pursuant to the NEF - ECS)
2011-03-08
1
ORDER that Case No. 2:10-cv-1166-GMN-RJJ is transferred to the Honorable Kent J. Dawson, United States District Judge for the District of Nevada. Case reassigned to Judge Kent J. Dawson for all further proceedings. Judge Gloria M. Navarro no longer assigned to case. All further documents must bear the correct case number 2:10-CV-1166 KJD-GWF. Signed by Judge Gloria M. Navarro on 3/9/11. (Copies have been distributed pursuant to the NEF - ECS) (Entered: 03/09/2011)
2011-03-09
1
MOTION to Shorten Time regarding dispositive matter by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc. Responses due by 4/23/2011. (Whitmire, III, James) Event type corrected on 4/6/2011. (MJZ) (Entered: 04/06/2011)
2011-04-06
1
ORDER that Defendants Motion to Schedule Claim Construction Proceedings 34 is GRANTED. Defendants Motion for Concurrent Claim Construction Proceedings 42 is DENIED as moot. Signed by Judge Kent J. Dawson on 4/8/11. (Copies have been distributed pursuant to the NEF - ECS) (Entered: 04/11/2011)
2011-04-08
1
MINUTE ORDER IN CHAMBERS of the Honorable Magistrate Judge Robert J. Johnston, on 4/13/2011. By Deputy Clerk: MXS. Upon review the court finds that the dates proposed in 36 Proposed Discovery Plan/Scheduling Order have passed. Therefore, on or before April 20, 2011, parties shall file a joint supplement to 36 advising the court if the dates proposed therein are sufficient or alternatively, shall provide a new proposed schedule. (no image attached) (Copies have been distributed pursuant to the NEF - MXS) (Entered: 04/13/2011)
2011-04-13
1
NOTICE OF RELATED CASES 11-00604 by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 04/19/2011)
2011-04-19
1
PROPOSED Discovery Plan/Scheduling Order filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 04/20/2011)
2011-04-20
1
THIRD STIPULATED SCHEDULING ORDER. Discovery due by 5/20/2011. Motions due by 6/20/2011. Proposed Joint Pretrial Order due by 7/20/2011. Signed by Magistrate Judge Robert J. Johnston on 5/11/11. (Copies have been distributed pursuant to the NEF - ECS) (Entered: 05/12/2011)
2011-05-11
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Adam K. Mortara and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993966) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 5/20/2011. (McCue, Michael) 53 Corrected image filed on 5/20/2011. (MJZ) (Entered: 05/20/2011)
2011-05-20
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Matthew R. Ford and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993986) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 5/20/2011. (McCue, Michael) 54 Corrected image filed on 5/20/2011. (MJZ) (Entered: 05/20/2011)
2011-05-20
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Paul J. Skiermont and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993996) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 5/20/2011. (McCue, Michael) 55 Corrected image filed on 5/20/2011. (MJZ) (Entered: 05/20/2011)
2011-05-20
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Peter B. Bensinger, Jr. and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1994004) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 5/20/2011. (McCue, Michael) 56 Corrected image filed on 5/20/2011. (MJZ) (Entered: 05/20/2011)
2011-05-20
1
VERIFIED PETITION for Permission to Practice Pro Hac Vice by Sundeep K. Addy and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1994013) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 5/20/2011. (McCue, Michael) 57 Corrected image filed on 5/20/2011. (MJZ) (Entered: 05/20/2011)
2011-05-20
1
NOTICE of Corrected Image/Document re 48 VERIFIED PETITION for Permission to Practice Pro Hac Vice by Adam K. Mortara and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993966) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Ph VERIFIED PETITION for Permission to Practice Pro Hac Vice by Adam K. Mortara and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993966) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Ph by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Service of corrected image is attached). (McCue, Michael) (Entered: 05/20/2011)
2011-05-20
1
NOTICE of Corrected Image/Document re 49 VERIFIED PETITION for Permission to Practice Pro Hac Vice by Matthew R. Ford and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993986) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Ph VERIFIED PETITION for Permission to Practice Pro Hac Vice by Matthew R. Ford and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993986) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Ph by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Service of corrected image is attached). (McCue, Michael) (Entered: 05/20/2011)
2011-05-20
1
NOTICE of Corrected Image/Document re 50 VERIFIED PETITION for Permission to Practice Pro Hac Vice by Paul J. Skiermont and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993996) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering VERIFIED PETITION for Permission to Practice Pro Hac Vice by Paul J. Skiermont and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1993996) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Service of corrected image is attached). (McCue, Michael) (Entered: 05/20/2011)
2011-05-20
1
NOTICE of Corrected Image/Document re 51 VERIFIED PETITION for Permission to Practice Pro Hac Vice by Peter B. Bensinger, Jr. and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1994004) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Sch VERIFIED PETITION for Permission to Practice Pro Hac Vice by Peter B. Bensinger, Jr. and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1994004) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Sch by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Service of corrected image is attached). (McCue, Michael) (Entered: 05/20/2011)
2011-05-20
1
NOTICE of Corrected Image/Document re 52 VERIFIED PETITION for Permission to Practice Pro Hac Vice by Sundeep K. Addy and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1994013) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Ph VERIFIED PETITION for Permission to Practice Pro Hac Vice by Sundeep K. Addy and DESIGNATION of Local Counsel Michael McCue (Filing fee $ 175 receipt number 0978-1994013) filed by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Ph by Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Service of corrected image is attached). (McCue, Michael) (Entered: 05/20/2011)
2011-05-20
1
ORDER granting 52 Verified Petition for Permission for Attorney Sundeep K. Addy to Practice Pro Hac Vice and approving Designation of Attorney Michael McCue as Local Counsel. Signed by Judge Kent J. Dawson on 5/23/11. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - ECS) (Entered: 05/25/2011)
2011-05-23
1
ORDER granting 49 Verified Petition for Permission for Attorney Matthew Ford to Practice Pro Hac Vice and approving Designation of Attorney Michael McCue as Local Counsel. Signed by Judge Kent J. Dawson on 5/23/11. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - ECS) (Main Document 58 replaced on 5/25/2011) (PAV). (Entered: 05/24/2011)
2011-05-24
1
ORDER granting 50 Verified Petition for Permission for Attorney Paul J. Skiermont to Practice Pro Hac Vice and approving Designation of Attorney Michael McCue as Local Counsel. Signed by Judge Kent J. Dawson on 5/23/11. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - ECS) (Main Document 59 replaced on 5/25/2011) (PAV). (Entered: 05/24/2011)
2011-05-24
1
ORDER granting 51 Verified Petition for Permission for Attorney Peter B. Bensinger Jr. to Practice Pro Hac Vice and approving Designation of Attorney Michael McCue as Local Counsel. Signed by Judge Kent J. Dawson on 5/23/11. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - ECS) (Entered: 05/24/2011)
2011-05-24
1
ORDER granting 48 Verified Petition for Permission for Attorney Adam K. Mortara to Practice Pro Hac Vice and approving Designation of Attorney Michael McCue as Local Counsel. Signed by Judge Kent J. Dawson on 5/23/11. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - ECS) (Entered: 05/24/2011)
2011-05-24
1
NOTICE of Corrected Image/Document re 58 Order on Verified Petition for Permission to Practice Pro Hac Vice,, 59 Order on Verified Petition for Permission to Practice Pro Hac Vice, (CM/ECF NEFs for these two orders were regenerated after the images were replaced.) (PAV) (Entered: 05/25/2011)
2011-05-25
1
MOTION for Summary Judgment of Infringement of Claims 13 and 15 of U.S. Reissue Patent No. 37,564 and for No Inequitable Conduct and Memorandum of Points and Authorities in Support by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Responses due by 7/14/2011. (Attachments: # 1 Statement of Material Facts, # 2 Declaration Declaration of Matthew R. Ford, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9)(Fountain, Jonathan) (Entered: 06/20/2011)
2011-06-20
1
MOTION to Seal 64 MOTION for Summary Judgment of Infringement of Claims 13 and 15 of U.S. Reissue Patent No. 37,564 and for No Inequitable Conduct and Memorandum of Points and Authorities in Support by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 6/20/2011. (Fountain, Jonathan) (Entered: 06/20/2011)
2011-06-20
1
MOTION for Summary Judgment by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Responses due by 7/14/2011. (Attachments: # 1 Statement of Undisputed Material Facts, # 2 Declaration of Kate M. Lesciotto, # 3 Exhibits 1 through 6, # 4 Exhibits 7 through 15, # 5 Exhibits 16 through 18, # 6 Exhibits 19 through 23, # 7 Exhibit 24, # 8 Exhibits 25 through 33)(Whitmire, III, James) (Entered: 06/20/2011)
2011-06-20
1
MOTION for Summary Judgment Of Non-Obviousness Of Claims 13 And 15 Of United States Reissue Patent No. 37,564 And Memorandum Of Points And Authorities In Support by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Responses due by 7/14/2011. (Attachments: # 1 Statement of Material Facts, # 2 Declaration Sundeep K. Addy, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28, # 31 Exhibit 29, # 32 Exhibit 30, # 33 Exhibit 31, # 34 Exhibit 32, # 35 Exhibit 33, # 36 Exhibit 34, # 37 Exhibit 35, # 38 Exhibit 36, # 39 Exhibit 37, # 40 Exhibit 38, # 41 Exhibit 39, # 42 Exhibit 40, # 43 Exhibit 41, # 44 Exhibit 42, # 45 Exhibit 43, # 46 Exhibit 44, # 47 Exhibit 45, # 48 Exhibit 46, # 49 Exhibit 47, # 50 Exhibit 48, # 51 Exhibit 49, # 52 Exhibit 50, # 53 Exhibit 51, # 54 Exhibit 52, # 55 Exhibit 53, # 56 Exhibit 54, # 57 Exhibit 55, # 58 Exhibit 56)(Fountain, Jonathan) (Entered: 06/20/2011)
2011-06-20
1
MOTION to Seal 67 MOTION for Summary Judgment and Related Documents by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 6/20/2011. (Whitmire, III, James) (Entered: 06/20/2011)
2011-06-20
1
MOTION to Seal 68 MOTION for Summary Judgment Of Non-Obviousness Of Claims 13 And 15 Of United States Reissue Patent No. 37,564 And Memorandum Of Points And Authorities In Support by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 6/20/2011. (Fountain, Jonathan) (Entered: 06/20/2011)
2011-06-20
1
STIPULATION and Proposed Order Regarding Briefing Schedule for Summary Judgment Responses by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 06/30/2011)
2011-06-30
1
ORDER ON STIPULATION Granting 72 Stipulation for Extension of Time to Files Responses to 64, 67, and 68 MOTIONS for Summary Judgment. Responses due by 7/15/2011. Signed by Judge Kent J. Dawson on 7/1/11. (Copies have been distributed pursuant to the NEF - ASB) (Entered: 07/01/2011)
2011-07-01
1
NOTICE of Change of Address by Jonathan W Fountain. for Paul J. Skiermont (Fountain, Jonathan) (Entered: 07/14/2011)
2011-07-14
1
STIPULATION FOR EXTENSION OF TIME (Second Request) re 64 MOTION for Summary Judgment of Infringement of Claims 13 and 15 of U.S. Reissue Patent No. 37,564 and for No Inequitable Conduct and Memorandum of Points and Authorities in Support ; by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc., Counter Claimants Lupin Ltd, Lupin Pharmaceuticals Inc.. (Whitmire, III, James) (Entered: 07/15/2011)
2011-07-15
1
OBJECTION /Evidentiary Objections to Bayer's Motion (and Statement of Facts in Support of Motion) for Summary Judgment [Doc. 68] of Non-Obviousness of Claims 13 and 15 of United States Reissue Patent No. 37,564 filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. (Whitmire, III, James) (Entered: 07/15/2011)
2011-07-15
1
RESPONSE to Statement re 68 Motion for Summary Judgment; filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc. (Whitmire, III, James) Docket entry relationship added on 7/19/2011. (MJZ) (Entered: 07/15/2011)
2011-07-15
1
RESPONSE to 67 MOTION for Summary Judgment, filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Replies due by 8/1/2011. (Attachments: # 1 Bayer's Response to Lupin's Statement of Material Facts, # 2 Declaration Sundeep K. Addy, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21, # 24 Exhibit 22, # 25 Exhibit 23, # 26 Exhibit 24, # 27 Exhibit 25, # 28 Exhibit 26, # 29 Exhibit 27, # 30 Exhibit 28)(Fountain, Jonathan) (Entered: 07/15/2011)
2011-07-15
1
RESPONSE to 68 MOTION for Summary Judgment Of Non-Obviousness Of Claims 13 And 15 Of United States Reissue Patent No. 37,564 And Memorandum Of Points And Authorities In Support, filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Replies due by 8/1/2011. (Attachments: # 1 Declaration of Kate Lesciotto, # 2 Exhibits 1-2, # 3 Exhibits 3-5, # 4 Exhibits 6-11, # 5 Exhibits 12-15, # 6 Exhibits 16-20, # 7 Exhibits 21-22, # 8 Exhibit 23, # 9 Exhibit 24-1, # 10 Exhibit 24-2, # 11 Exhibit 25, # 12 Exhibits 26-29)(Whitmire, III, James) (Entered: 07/15/2011)
2011-07-15
1
MOTION to Seal 77 Response - Other, 79 Response to Motion,, by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 7/15/2011. (Whitmire, III, James) (Entered: 07/15/2011)
2011-07-15
1
MOTION to Seal Exhibits to Docket No. 81 (Declaration of Sundeep K. Addy) by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 7/15/2011. (Fountain, Jonathan) (Entered: 07/15/2011)
2011-07-15
1
ORDER GRANTING 75 Stipulation to Extend Deadline. Responses due by 7/26/2011 re 64 MOTION for Summary Judgment of Infringement of Claims 13 and 15 of U.S. Reissue Patent No. 37,564 and for No Inequitable Conduct and Memorandum of Points and Authorities in Support. Signed by Judge Kent J. Dawson on 7/18/11. (Copies have been distributed pursuant to the NEF - ECS) (Entered: 07/18/2011)
2011-07-18
1
ORDER granting 82 Motion to Seal Declaration of Sundeep K. Addy. Signed by Magistrate Judge Robert J. Johnston on 7/21/11. (Copies have been distributed pursuant to the NEF - ECS)
2011-07-21
1
STATEMENT of Nonliability and Covenant Not to Sue Lupin Regarding U.S. Reissue Patent Nos. 37,838 and 38,253 and U.S. Patent Nos. 5,798,338, 6,933,395, 6,958,326, and 7,163,931 by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 07/22/2011)
2011-07-22
1
STIPULATION Regarding Infringement and Enforceability of U.S. Reissue Patent No. 37,564 by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Attachments: # 1 Proposed Order Regarding Infringement and Enforceability of U.S. Reissue Patent No. 37,564)(Fountain, Jonathan) (Entered: 07/22/2011)
2011-07-22
1
OBJECTION /Evidentiary Objections to Bayer's Memorandum of Points and Authorities in Opposition [Doc. 78] to the Lupin Defendants' Motion for Summary Judgment that the Claims of United States Reissue Patent No. 37,564 are Invalid as Obvious filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. (Whitmire, III, James) (Entered: 07/25/2011)
2011-07-25
1
REPLY to Response to 67 MOTION for Summary Judgment ; filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. (Attachments: # 1 Defendants Lupin Limited's and Lupin Pharmaceuticals, Inc.'s Reply to Bayer's Responses [Doc. 78-1] to Lupin's Statement of Material Facts in Support of Lupin's Motion for Summary Judgment that the Claims of United States Reissue Patent No. 37,564 are Invalid as Obvious, # 2 Supplemental Declaration of Kate M. Lesciotto, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Whitmire, III, James) (Entered: 07/25/2011)
2011-07-25
1
MOTION to Seal 88 Reply to Response to Motion,, Motion to File under Seal Certain "Confidential" Exhibits Accompanying the Supplemental Declaration of Kate M. Lesciotto [Doc. 88-2] by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Motion ripe 7/25/2011. (Whitmire, III, James) (Entered: 07/25/2011)
2011-07-25
1
REPLY to Response to 68 MOTION for Summary Judgment Of Non-Obviousness Of Claims 13 And 15 Of United States Reissue Patent No. 37,564 And Memorandum Of Points And Authorities In Support ; filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Attachments: # 1 Declaration Sundeep K. Addy, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4)(Fountain, Jonathan) (Entered: 07/25/2011)
2011-07-25
1
ORDER granting Defendants Lupin Limited's and Lupin Pharmaceutical's Motion 89 to File Under Seal Certain "Confidential" Exhibits Accompanying the Supplemental Declaration of Kate M. Lesciotto in Support of Lupin's Motion for Summary Judgment that the Claims of the U.S. Reissue Patent are Invalid as Obvious 88 . Signed by Magistrate Judge Robert J. Johnston on 7/26/11. (Copies have been distributed pursuant to the NEF - ECS)
2011-07-26
1
ORDER granting 80 Motion to Seal. Signed by Judge Kent J. Dawson on 7/28/2011. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 07/28/2011)
2011-07-28
1
ORDER ON STIPULATION Granting 86 Stipulation Regarding Infringement and Enforceability of US Reissue Patent No. 37,564 and Withdrawing 64 MOTION for Summary Judgment. Signed by Judge Kent J. Dawson on 7/28/11. (Copies have been distributed pursuant to the NEF - ASB) (Entered: 07/29/2011)
2011-07-28
1
ORDER granting 69 Motion to Seal.; granting 71 Motion to Seal. Signed by Judge Kent J. Dawson on 8/9/2011. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 08/09/2011)
2011-08-09
1
MOTION to Strike 87 Objection to Document, and Alternative Response to Objections to Evidence Submitted by Bayer in Support of its Motion for Summary Judgment of Non-Obviousness of Claims 13 and 15 of the '564 Patent by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Responses due by 8/26/2011. (Attachments: # 1 Declaration Matthew R. Ford, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5)(Fountain, Jonathan) (Entered: 08/09/2011)
2011-08-09
1
MOTION to Seal Declaration Of Matthew R. Ford In Support Of Bayers Motion To Strike And Alternative Response To Objection To Evidence Submitted By Bayer In Support Of Its Motion For Summary Judgment Of Non-Obviousness Of Claims 13 And 15 Of The '564 Patent by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Motion ripe 8/9/2011. (Fountain, Jonathan) (Entered: 08/09/2011)
2011-08-09
1
ORDER granting 101 Motion to Seal Declaration Of Matthew R. Ford In Support Of Bayers Motion To Strike And Alternative Response To Objection To Evidence Submitted By Bayer In Support Of Its Motion For Summary Judgment Of Non-Obviousness Of Claims 13 And 15 Of The '564 Patent by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Signed by Judge Kent J. Dawson on 8/15/2011. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 08/15/2011)
2011-08-15
1
RESPONSE to 99 MOTION to Strike 87 Objection to Document, and Alternative Response to Objections to Evidence Submitted by Bayer in Support of its Motion for Summary Judgment of Non-Obviousness of Claims 13 and 15 of the '564 Patent MOTION to Strike 87 Objection to Document, and Alternative Response to Objections to Evidence Submitted by Bayer in Support of its Motion for Summary Judgment of Non-Obviousness of Claims 13 and 15 of the '564 Patent MOTION to Strike 87 Objection to Document, and Alternative Response to Objections to Evidence Submitted by Bayer in Support of its Motion for Summary Judgment of Non-Obviousness of Claims 13 and 15 of the '564 Patent, filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Replies due by 9/5/2011. (Whitmire, III, James) (Entered: 08/26/2011)
2011-08-26
1
ERRATA to 68 MOTION for Summary Judgment Of Non-Obviousness Of Claims 13 And 15 Of United States Reissue Patent No. 37,564 And Memorandum Of Points And Authorities In Support, 78 Response to Motion,,, ; filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 09/02/2011)
2011-09-02
1
REPLY to Response to 99 MOTION to Strike 87 Objection to Document, and Alternative Response to Objections to Evidence Submitted by Bayer in Support of its Motion for Summary Judgment of Non-Obviousness of Claims 13 and 15 of the '564 Patent MOTION to Strike 87 Objection to Document, and Alternative Response to Objections to Evidence Submitted by Bayer in Support of its Motion for Summary Judgment of Non-Obviousness of Claims 13 and 15 of the '564 Patent MOTION to Strike 87 Objection to Document, and Alternative Response to Objections to Evidence Submitted by Bayer in Support of its Motion for Summary Judgment of Non-Obviousness of Claims 13 and 15 of the '564 Patent ; filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 09/02/2011)
2011-09-02
1
ORDER Denying 67 Motion for Summary Judgment, Granting 68 Motion for Summary Judgment, Denying 98 Motion for Summary Judgment, and Denying 99 Motion to Strike. Signed by Judge Kent J. Dawson on 3/30/12. (Copies have been distributed pursuant to the NEF - ASB)
2012-03-30
1
CLERK'S JUDGMENT in favor of Bayer Healthcare Pharmaceuticals Inc. and Bayer Schering Pharma AG and against Lupin Ltd and Lupin Pharmaceuticals Inc. Signed by Clerk of Court, Lance S. Wilson on 4/11/12. (Copies have been distributed pursuant to the NEF - ASB) (Main Document 107 replaced on 4/11/2012) (ASB). (Entered: 04/11/2012)
2012-04-11
1
AO 120 - REPORT on the filing or determination of an action regarding a patent or trademark. E-mailed to the US Patent and Trademark Office. (Attachments: # 1 Order, # 2 Judgment) (ASB) (Attachment 2 replaced on 4/11/2012) (ASB). (Entered: 04/11/2012)
2012-04-11
1
MOTION Pursuant to 35 U.S.C. 271(e) to Reset the Effective Date of the FDA's Approval for the Defendants to Market Generic YAZ by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. Responses due by 5/4/2012. (Attachments: # 1 Exhibit 1)(Fountain, Jonathan) (Entered: 04/17/2012)
2012-04-17
1
NOTICE of Association of Counsel by James E Whitmire, III on behalf of Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. (Whitmire, III, James) (Entered: 05/03/2012)
2012-05-03
1
RESPONSE to 109 MOTION Pursuant to 35 U.S.C. 271(e) to Reset the Effective Date of the FDA's Approval for the Defendants to Market Generic YAZ MOTION Pursuant to 35 U.S.C. 271(e) to Reset the Effective Date of the FDA's Approval for the Defendants to Market Generic YAZ, filed by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Replies due by 5/13/2012. (Whitmire, III, James) (Entered: 05/03/2012)
2012-05-03
1
NOTICE OF APPEAL as to 106 Order on Motion for Summary Judgment,,, Order on Motion to Strike,,,, 107 Clerk's Judgment, by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc.. Filing fee $ 455, receipt number 0978-2356997. (Whitmire, III, James) (Entered: 05/03/2012)
2012-05-03
1
Designation of Transcripts and Transcript Order forms and instructions for 112 Notice of Appeal,. The forms may also be obtained on the Court's website at www.nvd.uscourts.gov/Forms.aspx. (ECS) (Entered: 05/04/2012)
2012-05-04
1
TRANSCRIPT DESIGNATION by Defendants Lupin Ltd, Lupin Pharmaceuticals Inc. re 112 Notice of Appeal,. Transcripts are NOT required for this appeal. (Whitmire, III, James) (Entered: 05/11/2012)
2012-05-11
1
CERTIFICATE OF RECORD on 112 Notice of Appeal. The record on appeal, consisting of the reporter's transcripts and the United States District Court clerk's record is ready for the purpose of the appeal. This file exists in electronic format and is accessible via CM/ECF - PACER. The documents comprising the United States District Court clerk's record have been numbered in conformance with Rule 11(b) of the Federal Rules of Appellate Procedure. These document numbers are reflected on the United States District Court's docket sheet and should be used for reference purposes in the briefs. Appeals in Habeas Corpus and 28 USC 2255 Motion to Vacate Sentence cases are treated as civil appeals in the Court of Appeals. Criminal appeals briefing schedules will be issued upon the filing of this document. Notice sent to the Federal Circuit Court of Appeals. (no image attached) (ECS, cc: Fed Cir) (Entered: 05/14/2012)
2012-05-14
1
TRANSMITTAL of Notice of Appeal and Docket Sheet to Federal Circuit Court of Appeals re 112 Notice of Appeal. (Attachments: # 1 Appeal, # 2 Certificate of Record)(ECS) (Entered: 05/14/2012)
2012-05-14
1
REPLY to Response to 109 MOTION Pursuant to 35 U.S.C. 271(e) to Reset the Effective Date of the FDA's Approval for the Defendants to Market Generic YAZ MOTION Pursuant to 35 U.S.C. 271(e) to Reset the Effective Date of the FDA's Approval for the Defendants to Market Generic YAZ ; filed by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 05/14/2012)
2012-05-14
1
Notice of Docketing from US Court of Appeals for the Federal Circuit re 112 Notice of Appeal. Case Number 12-1424. (ECS) (Entered: 06/08/2012)
2012-06-08
1
ORDER Granting 109 Plaintiffs' Motion to Reset the Effective Date of the FDA's approval for the Defendants to Market Generic YAZ. IT IS FURTHER ORDERED that the effective date of the FDAs approval of Lupins YAZ ANDA be set no earlier than June 30, 2014. IT IS FURTHER ORDERED that Plaintiffs shall serve a copy of this order on the FDA. Signed by Judge Kent J. Dawson on 2/11/13. (Copies have been distributed pursuant to the NEF - EDS)
2013-02-11
1
NOTICE OF RELATED CASES 2:07-01472; 2:11-cv-00054; 2:11-cv-00604; 2:13-cv-00265 by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 03/11/2013)
2013-03-11
1
OPINION re 112 Notice of Appeal. REVERSED. (SLR) (Additional attachment(s) added on 4/17/2013: # 1 Judgment) (SLR). (Entered: 04/17/2013)
2013-04-16
1
RECALLED per 125 ORDER (AC) MANDATE of USCA, Federal Circuit, as to 121 Opinion, 112 Notice of Appeal. REVERSED. (SLR) Modified on 8/21/2013 (AC). (Entered: 05/30/2013)
2013-05-29
1
ORDER on Mandate as to 121 Opinion and 122 USCA Mandate Reversing Judgment of the US District Court re 112 Notice of Appeal, filed by Lupin Ltd, Lupin Pharmaceuticals Inc. Signed by Judge Kent J. Dawson on 5/31/13. (EDS) (Entered: 06/03/2013)
2013-05-31
1
ORDER of USCA, Federal Circuit, as to 112 Notice of Appeal filed by Lupin Ltd, Lupin Pharmaceuticals Inc. The Mandate having been issued in error, it is ORDERED that the mandate be, and the same hereby is, RECALLED. (AC) (Entered: 08/21/2013)
2013-06-21
1
MANDATE of USCA, Ninth Circuit, as to 121 USCA Opinion and 112 Notice of Appeal. REVERSED. Costs in the amount of $1287.64 were determined and taxed against the appellee. (Attachments: # 1 Judgment, # 2 Opinion) (AC) (Entered: 08/21/2013)
2013-08-20
1
ORDER on Mandate as to 126 USCA Mandate and 121 USCA Opinion REVERSING judgment of the US District Court re 112 Notice of Appeal, filed by Lupin Ltd, Lupin Pharmaceuticals Inc.. Signed by Judge Kent J. Dawson on 8/22/13. (EDS) (Entered: 08/23/2013)
2013-08-22
1
NOTICE of Firm Name Change; filed by Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 09/06/2013)
2013-09-06
1
MINUTE ORDER IN CHAMBERS of the Honorable Judge Kent J. Dawson, on 10/2/2013. The parties are ordered to file a joint status report within fourteen (14) days of the entry of this order. (no image attached) (Copies have been distributed pursuant to the NEF - BXS) (Entered: 10/02/2013)
2013-10-02
1
Joint STATUS REPORT by Counter Defendants Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG, Plaintiffs Bayer Healthcare Pharmaceuticals Inc., Bayer Schering Pharma AG. (Fountain, Jonathan) (Entered: 10/16/2013)
2013-10-16
1
ORDER Closing Case re 131 Joint Status Report filed by Bayer Schering Pharma AG and Bayer Healthcare Pharmaceuticals Inc. Signed by Judge Kent J. Dawson on 11/26/13. (Copies have been distributed pursuant to the NEF - EDS)
2013-11-27
1
AO 120 - REPORT on the filing or determination of an action regarding a patent or trademark. E-mailed to the US Patent and Trademark Office. (Attachments: # 1 order) (EDS) (Main Document 133 replaced on 11/27/2013) (EDS). (Entered: 11/27/2013)
2013-11-27
1